国际简称:J PEDIATR NEONATAL I 参考译名:儿科和新生儿个体化医疗杂志
主要研究方向:PEDIATRICS 非预警期刊 审稿周期: 12 Weeks
《儿科和新生儿个体化医疗杂志》(Journal Of Pediatric And Neonatal Individualized Medicine)是一本由Hygeia Press di Corridori Marinella出版的以PEDIATRICS为研究特色的国际期刊,发表该领域相关的原创研究文章、评论文章和综述文章,及时报道该领域相关理论、实践和应用学科的最新发现,旨在促进该学科领域科学信息的快速交流。该期刊是一本开放期刊,近三年没有被列入预警名单。
The Journal of Pediatric and Neonatal Individualized Medicine is a professional journal dedicated to the fields of pediatrics and neonatal medicine. Emphasizing the importance of personalized medicine, aiming to publish innovative research, clinical observations, reviews, and other content related to pediatrics and neonatal health. It covers a wide range of areas, from basic scientific research to clinical practice.
Its goal is to promote a deeper understanding of diseases in children and newborns, and to advance the development of precision medical methods for individual patients. By publishing high-quality articles, it provides a platform for pediatricians, neonatologists, medical researchers, and other related professionals to exchange and share the latest research results and clinical experiences. The articles in the magazine cover multiple topics, including but not limited to children's growth and development, diagnosis and treatment of pediatric diseases, neonatal care and health issues, the impact of genetic factors on children's health, and the development of personalized treatment plans. It encourages the use of interdisciplinary approaches to explore issues in these fields, in order to promote cooperation and knowledge integration between different professions.
CiteScore | SJR | SNIP | CiteScore 指数 | ||||||||
1 | 0.158 | 0.2 |
|
名词解释:CiteScore 是衡量期刊所发表文献的平均受引用次数,是在 Scopus 中衡量期刊影响力的另一个指标。当年CiteScore 的计算依据是期刊最近4年(含计算年度)的被引次数除以该期刊近四年发表的文献数。例如,2022年的 CiteScore 计算方法为:2022年的 CiteScore =2019-2022年收到的对2019-2022年发表的文件的引用数量÷2019-2022年发布的文献数量 注:文献类型包括:文章、评论、会议论文、书籍章节和数据论文。
按JIF指标学科分区 | 收录子集 | 分区 | 排名 | 百分位 |
学科:PEDIATRICS | ESCI | Q4 | 164 / 186 |
12.1% |
按JCI指标学科分区 | 收录子集 | 分区 | 排名 | 百分位 |
学科:PEDIATRICS | ESCI | Q4 | 170 / 186 |
8.87% |